Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.01M Sell
105,532
-190,959
-64% -$3.69M ﹤0.01% 2907
2025
Q4
$4.85M Sell
296,491
-66,704
-18% -$1.17M ﹤0.01% 2324
2025
Q3
$6.82M Sell
363,195
-136,322
-27% -$2.44M ﹤0.01% 1966
2025
Q2
$10.1M Sell
499,517
-1,318,756
-73% -$22.8M 0.01% 1482
2025
Q1
$25M Buy
1,818,273
+1,645,260
+951% +$22.7M 0.02% 810
2024
Q4
$2.05M Sell
173,013
-3,019,108
-95% -$47.5M ﹤0.01% 2714
2024
Q3
$57.3M Buy
3,192,121
+121,267
+4% +$2.21M 0.05% 457
2024
Q2
$54M Buy
3,070,854
+19,363
+0.6% +$400K 0.05% 430
2024
Q1
$78.3M Sell
3,051,491
-477,949
-14% -$12M 0.07% 336
2023
Q4
$92M Buy
3,529,440
+2,033,401
+136% +$46.4M 0.08% 293
2023
Q3
$34.5M Buy
+1,496,039
New +$37.5M 0.04% 575
2021
Q1
Sell
-62,938
Closed -$2.5M 4543
2020
Q4
$2.5M Buy
+62,938
New +$2.57M ﹤0.01% 2413
2020
Q2
Sell
-60,881
Closed -$1.17M 4293
2020
Q1
$1.17M Buy
+60,881
New +$2.06M ﹤0.01% 2614

Other funds holding XP

D.E. Shaw & Co's XP Position: Q1 2026 in Review

D.E. Shaw & Co reduced its XP (XP) stake by 64% in Q1 2026, selling an estimated $3.69M and leaving 105,532 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

D.E. Shaw & Co first reported a position in XP in Q1 2020 and has held it in 13 quarters since. The position peaked at $92M in Q4 2023. 356 funds tracked by Wall St. Rank hold XP as of Q1 2026.

  • D.E. Shaw & Co held 105,532 shares of XP worth $2.01M as of Q1 2026.
  • D.E. Shaw & Co sold 190,959 XP shares in Q1 2026, an estimated $3.69M.
  • XP made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2907 holding.
  • D.E. Shaw & Co first reported a position in XP in Q1 2020 and has held it in 13 quarters since.
  • D.E. Shaw & Co's XP position peaked at $92M in Q4 2023.
  • 356 funds tracked by Wall St. Rank held XP as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.